Key result
Editors of major cardiovascular journals have resolved to implement guidelines requiring the prospective incorporation and disaggregated reporting of sex and gender in cardiovascular research.
Answers are grounded in this paper and cite their sources.
Major cardiovascular journals have committed to enforcing standardized reporting of sex and gender in research to improve scientific rigor and clinical outcomes for all patients.
Understanding sex and gender is critical to promoting human health and targeting disease.1 Although sex is often incorrectly thought to have the same meaning as gender, the terms describe different constructs. Sex is a multidimensional biological construct based on anatomy, physiology, genetics, and hormones. These components are sometimes referred to together as sex traits. Gender can be broadly defined as a multidimensional construct that encompasses social and cultural expectations about status, characteristics, and behavior as they are associated with certain sex traits.2 Cardiovascular research, similar to other areas of clinical investigation, does not always or consistently disaggregate results based on patients’ sex. Laboratory research, essential for the groundwork for human investigation, also does not consistently provide data stratified by sex. Change in these practices is essential to respond to the need for data on women due to their historical underrepresentation in clinical trials and inattention to sex as a biological variable that exists in varying degrees.3 Without such change, diagnosis, treatment, and prevention of disorders in women are substantially compromised.4–7 Moreover, not understanding sex-specific differences limits our capacity to better inform care for both women and men. As such, improving how research is reported in journals would benefit all patients. The Sex and Gender Equity in Research (SAGER) guidelines address the use of the terms sex and gender8 and the value of designing studies to generate and report data on the basis of sex and gender. Inattention to high-quality standards of scientific reporting reduces scientific rigor and can lead to unwanted clinical outcomes.9,10 Representatives of the editorial boards of 4 cardiovascular journals (Circulation, European Heart Journal, JAMA Cardiology, and Journal of the American College of Cardiology) met in October 2024 at the invitation of the White House Initiative on Women’s Health Research to discuss the role of cardiovascular disease journals in the reporting of sex and gender in research. In attendance were leaders of the White House Initiative, representatives of the National Institutes of Health, and aligned organizations, including the American Heart Association, the American College of Cardiology, JAMA, and the National Academy of Medicine. Also attending were editors of orthopedic surgery journals who have worked to increase data and reporting on women in their specialty. Following this meeting, the Editors in Chief of cardiovascular journals have convened, seeking concurrence on key themes pertaining to the reporting of sex and gender in cardiovascular research. The editors who are listed in the byline of this Editorial have agreed to the following resolutions: We support the SAGER guidelines11 or we have our own published guidelines that are similar.12 Specifically, we recommend participants be characterized by sex and/or gender and cell lines, tissues, and animals be characterized by sex. If relevant, we strongly recommend that researchers describe how sex and/or gender were considered in the study design and analytic approach. We also recommend that researchers consider whether disaggregation by sex and/or gender and the intersectionality of sex/gender with other biological and social constructs are relevant. Additionally, researchers should consider the extent to which the results of the study are generalizable to all sexes/genders. If sex and/or gender are considered to be important to the research question, but are not feasible to analyze (eg, underpowered to stratify by sex/gender), this should be discussed as a possible limitation. We recommend that clinical researchers report whether sex and gender were ascertained based on self-report or assigned by the investigators, defining the criteria utilized to this end. We refer authors to the SAGER guidelines for terminology.8 Each journal will implement a tailored process to address sex and gender considerations. This process will prompt authors to consider whether and how sex and/or gender are addressed when appropriate, provide explanations for missingness where applicable, consider the appropriateness of data disaggregation, and incorporate hypotheses or conceptual models to support analytic plans related to sex and/or gender. We recognize as editors that journals are on the receiving end of research that has already been completed, but our goal is to influence the upstream process of research. We hope that by making these resolutions we may impact representatives on institutional review boards, institutional animal care and use committees, clinical trial steering committees, and/or funding agencies and organizations to require the incorporation of sex and gender prospectively in scientific investigation. Conflict of Interest Disclosures: Dr Bairey Merz reported serving on the Board of Directors of and holding stock in iRhythm. Dr Mehran reported institutional research payments from Abbott, Alleviant Medical, Beth Israel Deaconess Medical Center, Concept Medical, Cordis, CPC Clinical Research, Elixir Medical, Faraday Pharmaceuticals, Idorsia, Janssen, MedAlliance, MediaSphere Medical, Medtronic, Novartis, Protembis GmbH, RM Global BioAccess Fund, and Sanofi US Services; personal fees from Elixir Medical, IQVIA, Medscape/WebMD Global, Medtronic, and Novo Nordisk; personal fees from and holding equity (<1%) in ControlRad, Elixir Medical, and Stel Life; nonfinancial support from serving as a faculty member for the Cardiovascular Research Foundation, as a Women in Innovations Committee member for the Society for Cardiovascular Angiography and Interventions, and as founding director of Women as One; and receiving honorarium from the American College of Cardiology. No other disclosures were reported. Additional Contributions: We thank Carolyn M. Mazure, PhD (Yale School of Medicine), for her efforts as the Chair of the White House Initiative on Women’s Health Research. We also wish to thank the editors representing the orthopedic surgery journals for sharing their experiences in advancing the guidelines for their journals. Additional Information: This article is being simultaneously published in Circulation, European Heart Journal, JAMA Cardiology, Journal of the American College of Cardiology, European Journal of Preventive Cardiology, European Heart Journal – Cardiovascular Imaging, European Heart Journal – Acute Cardiovascular Care, European Heart Journal – Digital Health, European Journal of Cardiovascular Nursing, and European Heart Journal Open. Endorsed by the Following Editors in Chief of Cardiovascular Journals: Victor Aboyans, European Journal of Preventive Cardiology; Stefan Agewall, EHJ Cardiovascular Pharmacotherapy; Ferhaan Ahmad, Circulation: Genomic and Precision Medicine; Armin Arbab-Zadeh, Journal of Cardiovascular Computed Tomography; Dan Atar, Cardiology; Magnus Back, EHJ – Open; Subhash Banerjee, American Journal of Cardiology; Adrian Baranchuk, Journal of Electrocardiology; Yochai Birnbaum, Cardiovascular Drugs and Therapy; Michael Böhm, European Journal of Heart Failure; George W. Booz, Journal of Cardiovascular Pharmacology; Giuseppe Boriani, EP Europace; Biykem Bozkurt, JACC Heart Failure; Nico Bruining, EHJ Digital Health; T. Jared Bunch, Heart Rhythm Case Reports; A. John Camm, Clinical Cardiology; Y. S. Chandrashekhar, JACC: Cardiovascular Imaging; Joanna Chikwe, The Annals of Thoracic Surgery; Marcelo F. Di Carli, Journal of Nuclear Cardiology; Çetin Erol, Anatolian Journal of Cardiology; Roberto Ferrari, EHJ Supplements; Jane E. Freedman, Circulation Research; William H. Frishman and Peter Zimetbaum, Cardiology in Review; Bernard Gerber, EHJ Cardiovascular Imaging; Cindy L. Grines, Journal of Interventional Cardiology; Robert J. Gropler, Circulation: Cardiovascular Imaging; Tomasz Guzik, Cardiovascular Research; Jeffrey P. Jacobs, Cardiology in the Young; Bradley P. Knight, Journal of Cardiovascular Electrophysiology; Bonnie Ky, JACC: CardioOncology; Anuradha Lala, Journal of Cardiac Failure; Tim Leiner, Journal of Cardiovascular Magnetic Resonance; Douglas L. Mann, JACC: Basic to Translational Sciences; David J. Moliterno, JACC: Cardiovascular Interventions; Philip Moons, European Journal of Cardiovascular Nursing; Brahmajee K. Nallamothu, Circulation: Cardiovascular Quality and Outcomes; Peyman Sardari Nia, Interactive CardioVascular and Thoracic Surgery; Bruce Ovbiagele, Journal of the American Heart Association; G. Alexander Patterson, Journal of Thoracic and Cardiovascular Surgery; Jeanne E. Poole, Heart Rhythm O2; Kazem Rahimi, Heart; Sunil V. Rao, Circulation: Cardiovascular Interventions; Joseph Rogers, Journal of Heart and Lung Transplantation; Juan Sanchis, Revista Espanola de Cardiologia; Ann Marie Schmidt, Arteriosclerosis, Thrombosis, and Vascular Biology; Kalyanam Shivkumar, JACC: Clinical Electrophysiology; Matthias Siepe, European Journal of Cardio-Thoracic Surgery; Candice Silversides, JACC: Advances; Nancy K. Sweitzer, Circulation: Heart Failure; Gilbert H. L. Tang, JACC: Case Reports; Rong Tian, Journal of Molecular and Cellular Cardiology; Rhian Touyz, Hypertension; Pim van der Harst, Netherlands Heart Journal; Sami Viskin, Heart Rhythm; Pascal Vranckx, EHJ: Acute Cardiovascular Care; Jian’an Wang, JACC: Asia; and Paul Wang, Circulation: Arrhythmia and Electrophysiology.
No takes yet. Share an insight, caveat, or question.
Merz et al. (2025) conducted an editorial in Cardiovascular disease. Editors of major cardiovascular journals have resolved to implement guidelines requiring the prospective incorporation and disaggregated reporting of sex and gender in cardiovascular research.
Synapse has enriched 10 related papers. Consider them for comparative context: